Macrophage–tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter‐receptor for the macrophage‐restricted receptor, sialoadhesin
暂无分享,去创建一个
J. Burchell | Nath | Hartnell | Happerfield | Miles | Burchell | Taylor‐Papadimitriou | Crocker*§ | David Miles | Paul R. Crocker | Deepa Nath | J. Taylor-Papadimitriou | A. Hartnell | L. Happerfield
[1] J A Sherratt,et al. Pattern formation and spatiotemporal irregularity in a model for macrophage-tumour interactions. , 1997, Journal of theoretical biology.
[2] P. Crocker,et al. The species‐specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin‐positive macrophages occur in the perifollicular zone, but not in the marginal zone , 1997, Immunology.
[3] H. Stein,et al. Carbohydrate Recognition on MUC1‐Expressing Targets Enhances Cytotoxicity of a T Cell Subpopulation , 1997, Scandinavian journal of immunology.
[4] M. Griswold,et al. Role of E Box and Initiator Region in the Expression of the Rat Follicle-stimulating Hormone Receptor* , 1996, The Journal of Biological Chemistry.
[5] A. Harris,et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.
[6] P. Crocker,et al. Carbohydrate recognition systems: functional triads in cell-cell interactions. , 1996, Current opinion in structural biology.
[7] L. Pilarski,et al. The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. , 1996, Cancer research.
[8] J. Wesseling,et al. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. , 1996, Molecular biology of the cell.
[9] R. Cummings,et al. Visualization of P-selectin Glycoprotein Ligand-1 as a Highly Extended Molecule and Mapping of Protein Epitopes for Monoclonal Antibodies (*) , 1996, The Journal of Biological Chemistry.
[10] J. Peter-Katalinic,et al. MUC1 Glycoforms in Breast Cancer , 1996 .
[11] A. Krüger,et al. A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo. , 1996, Immunology.
[12] J. Peter-Katalinic,et al. MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation. , 1996, European journal of biochemistry.
[13] P. A. van der Merwe,et al. The Amino-terminal Immunoglobulin-like Domain of Sialoadhesin Contains the Sialic Acid Binding Site , 1995, The Journal of Biological Chemistry.
[14] I. Brockhausen,et al. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. , 1995, European journal of biochemistry.
[15] M. Donowitz,et al. Separate C-terminal Domains of the Epithelial Specific Brush Border Na+/H+ Exchanger Isoform NHE3 Are Involved in Stimulation and Inhibition by Protein Kinases/Growth Factors (*) , 1995, The Journal of Biological Chemistry.
[16] J O McGee,et al. Cytokine regulation of angiogenesis in breast cancer: the role of tumor‐associated macrophages , 1995, Journal of leukocyte biology.
[17] S. Gordon,et al. Sialoadhesin binds preferentially to cells of the granulocytic lineage. , 1995, The Journal of clinical investigation.
[18] M. Filbin,et al. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily , 1994, Current Biology.
[19] S. Gordon,et al. Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin‐like domains. , 1994, The EMBO journal.
[20] C. Lewis,et al. Tumour‐associated leucocytes: Friends or foes in breast carcinoma , 1994, The Journal of pathology.
[21] A. Harris,et al. Secretion of epidermal growth factor by macrophages associated with breast carcinoma , 1993, The Lancet.
[22] C. Melief,et al. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. , 1993, Journal of immunology.
[23] T. K. van den Berg,et al. Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule , 1992, The Journal of experimental medicine.
[24] J. Taylor‐Papadimitriou,et al. Antibodies to the cytoplasmic domain of the MUC1 mucin show conservation throughout mammals. , 1992, Biochemical and biophysical research communications.
[25] J. Taylor‐Papadimitriou,et al. The product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tail. , 1992, Biochemical and biophysical research communications.
[26] M. Ligtenberg,et al. Suppression of cellular aggregation by high levels of episialin. , 1992, Cancer research.
[27] A. Mantovani,et al. The origin and function of tumor-associated macrophages. , 1992, Immunology today.
[28] D. Shotton,et al. Purification and properties of sialoadhesin, a sialic acid‐binding receptor of murine tissue macrophages. , 1991, The EMBO journal.
[29] R. Bast,et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. , 1991, Cancer research.
[30] S. Gordon,et al. Expression of a divalent cation-dependent erythroblast adhesion receptor by stromal macrophages from murine bone marrow. , 1991, Journal of cell science.
[31] D. Shotton,et al. The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. , 1991, The EMBO journal.
[32] Z. Werb,et al. Ultrastructural localization of a macrophage-restricted sialic acid binding hemagglutinin, SER, in macrophage-hematopoietic cell clusters. , 1990, Blood.
[33] J. Taylor‐Papadimitriou,et al. A short sequence, within the amino acid tandem repeat of a cancer‐associated mucin, contains immunodominant epitopes , 1989, International journal of cancer.
[34] J. Bártková,et al. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM‐3 is selectively exposed in a range of primary carcinomas , 1989, International journal of cancer.
[35] D. Hayes,et al. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. , 1989, Cancer communications.
[36] J. Taylor‐Papadimitriou,et al. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. , 1987, Cancer research.
[37] T. Decker,et al. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. , 1987, Journal of immunology.
[38] J. Taylor‐Papadimitriou,et al. Detection of the tumour‐associated antigens recognized by the monoclonal antibodies hmfg‐1 and 2 in serum from patients with breast cancer , 1984, International journal of cancer.
[39] J. Taylor‐Papadimitriou,et al. Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. , 1983, Journal of immunology.